NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bioventus Inc (NASDAQ: BVS)

 
BVS Technical Analysis
5
As on 9th Jun 2023 BVS STOCK Price closed @ 2.71 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 9.88 & Strong Sell for SHORT-TERM with Stoploss of 13.38 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BVSSTOCK Price

Open 3.00 Change Price %
High 3.00 1 Day -0.31 -10.26
Low 2.69 1 Week -0.15 -5.24
Close 2.71 1 Month 1.71 171.00
Volume 472439 1 Year -10.53 -79.53
52 Week High 15.28 | 52 Week Low 0.93
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
BVS
Daily Charts
BVS
Intraday Charts
Whats New @
Bazaartrend
BVS
Free Analysis
 
BVS Important Levels Intraday
RESISTANCE3.31
RESISTANCE3.12
RESISTANCE3.00
RESISTANCE2.88
SUPPORT2.54
SUPPORT2.42
SUPPORT2.30
SUPPORT2.11
 
BVS Forecast April 2024
4th UP Forecast10.01
3rd UP Forecast7.67
2nd UP Forecast6.22
1st UP Forecast4.78
1st DOWN Forecast0.64
2nd DOWN Forecast-0.8
3rd DOWN Forecast-2.25
4th DOWN Forecast-4.59
 
BVS Weekly Forecast
4th UP Forecast5.93
3rd UP Forecast4.90
2nd UP Forecast4.26
1st UP Forecast3.62
1st DOWN Forecast1.80
2nd DOWN Forecast1.16
3rd DOWN Forecast0.52
4th DOWN Forecast-0.51
 
BVS Forecast2024
4th UP Forecast31.04
3rd UP Forecast21.95
2nd UP Forecast16.34
1st UP Forecast10.72
1st DOWN Forecast-5.3
2nd DOWN Forecast-10.92
3rd DOWN Forecast-16.53
4th DOWN Forecast-25.62
 
 
BVS Other Details
Segment EQ
Market Capital 853309504.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
BVS Address
BVS
 
BVS Latest News
 
Your Comments and Response on Bioventus Inc
 
BVS Business Profile
Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company provides osteoarthritic joint pain treatment and joint preservation products, including Durolane, a single injection therapy; GELSYN-3, a three injection therapy; and SUPARTZ FX, a five injection therapy. It also offers bone graft substitutes comprising allograft-derived bone graft with growth factors, demineralized bone matrix, cancellous bone in different preparations, bioactive synthetics, collagen ceramic matrix, and bone marrow isolation systems. In addition, the company provides Exogen systems for the non-invasive treatment of established nonunion fractures and certain fresh fractures. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina. Address: 4721 Emperor Boulevard, Durham, NC, United States, 27703
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service